Insights

Strategic Partnerships Bedrocan is actively expanding distribution through partnerships with Medios AG in Germany and plans to extend to Austria, Belgium, Italy and Spain, presenting a pathway for international distributor collaborations and co-marketing opportunities.

New Formulations The launch of Bedromed, a line of standardised cannabinoid-based formulations for sprays and sublingual oromucosal administration, opens upsell avenues into formulary-ready products and differentiated dosage forms for clinics and pharmacies.

EU GMP Footprint With an EU-GMP certified Denmark facility and prior GMP certification, Bedrocan strengthens supply reliability for European customers and can support scalable manufacturing for partner APIs and CBPMs.

One-Stop Ordering Introduction of a pharmacist-facing one-stop-shop procurement platform simplifies ordering, enabling faster sales cycles, improved compliance, and higher order throughput from pharmacy networks.

Public Sector Access Bedrocan supplies medicinal cannabis under government frameworks in the Netherlands and to international governments under special access programs, indicating potential for new government tenders, API supply deals, and long-term volume contracts.

Similar companies to Bedrocan

Bedrocan Tech Stack

Bedrocan uses 8 technology products and services including Hotjar, Visual Website Optimizer, Usercentrics, and more. Explore Bedrocan's tech stack below.

Media & News

Bedrocan's Email Address Formats

Bedrocan uses at least 4 email formats:
Bedrocan Email FormatsExamplePercentage
F.Last@bedrocan.comJ.Doe@bedrocan.com
94%
First-Last@bedrocan.comJohn-Doe@bedrocan.com
2%
First.Last@bedrocan.comJohn.Doe@bedrocan.com
2%
First@bedrocan.comJohn@bedrocan.com
2%

Frequently Asked Questions

What is Bedrocan's official website and social media links?

Minus sign iconPlus sign icon
Bedrocan's official website is bedrocan.com and has social profiles on LinkedIn.

How much revenue does Bedrocan generate?

Minus sign iconPlus sign icon
As of October 2026, Bedrocan's annual revenue is estimated to be $1M - $10M.

What is Bedrocan's NAICS code?

Minus sign iconPlus sign icon
Bedrocan's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Bedrocan have currently?

Minus sign iconPlus sign icon
As of October 2026, Bedrocan has approximately 82 employees across 2 continents, including Europe and North America. Key team members include Chief Executive Officer: J. E., Chief Financial Officer: H. S. and Head Of Corporate & Integrated Marketing Communications: F. S. Explore Bedrocan's employee directory with LeadIQ.

What industry does Bedrocan belong to?

Minus sign iconPlus sign icon
Bedrocan operates in the Pharmaceutical Manufacturing industry.

What technology does Bedrocan use?

Minus sign iconPlus sign icon
Bedrocan's tech stack includes Hotjar, Visual Website Optimizer, Usercentrics, WordPress, Shopify, Sentry, ActiveCampaign and Mautic.

What is Bedrocan's email format?

Minus sign iconPlus sign icon
Bedrocan's email format typically follows the pattern of F.Last@bedrocan.com. Find more Bedrocan email formats with LeadIQ.

When was Bedrocan founded?

Minus sign iconPlus sign icon
Bedrocan was founded in 1984.
Bedrocan logo

Bedrocan

Pharmaceutical ManufacturingGroningen, Netherlands51-200 Employees

Bedrocan is a mid-sized pharmaceutical manufacturer based in Veendam, in the Groningen region of the Netherlands. It produces pharmaceutical-grade, standardized medicinal cannabis intended for medical use and as an active pharmaceutical ingredient for cannabis-based products such as THC or CBD isolates, full-spectrum oils, CBD oil, and ointments. The cannabis varieties it develops are also used as Investigational Medical Products in clinical research, and the company supports an active research program published in scientific outlets.

Its products are delivered to pharmaceutical manufacturers by the Dutch Office of Medicinal Cannabis, and patients with a doctor’s prescription can obtain this medicinal cannabis at Dutch pharmacies. In the Netherlands, Bedrocan operates under a framework agreement with the Ministry of Health, and the Office of Medicinal Cannabis also supplies its products internationally under special access conditions as unapproved drugs; a recent development is the May 2026 launch of Bedromed, a line of standardized cannabinoid-based formulations by Bedrocan International.

Section iconCompany Overview

NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
1984
Employees
51-200

Section iconFunding & Financials

  • $1M - $10M

    Bedrocan's revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.